Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Seminars in Hematology|July 17, 2007
Hematopoietic growth factors for hematopoietic stem cell mobilization and expansionRobert Möhle, Lothar KanzRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
LenalidomideKatja Weisel, Lothar KanzBlood Reviews|October 27, 2004
Dendritic cells in vaccination therapies of human malignant diseaseVolker L Reichardt, Peter Brossart, Lothar KanzCurrent Opinion in Infectious Diseases|April 20, 2002
Molecular methods in the diagnosis of infections in the immunocompromised hostHolger Hebart, Juergen Loeffler, Lothar Kanz, et al.Anti-Cancer Drugs|August 31, 2006
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamideHans-Georg Kopp, Lothar Kanz, Joerg T HartmannDeutsche Medizinische Wochenschrift (1946)|October 23, 2009
[56-year-old patient with leg paresis, pulmonary infiltrates, and eosinophilia--Case 08/2009]Jörg Henes, Marius Horger, Lothar Kanz, et al.Deutsche Medizinische Wochenschrift (1946)|March 6, 2018
[Follow-up Care in Cancer: Selected Solid Tumors and Hematological Neoplasias]Malte Rörden, Clemens Hinterleitner, Janina Metzger, et al.Annals of the New York Academy of Sciences|June 17, 2005
The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cellsGabriele Seitz, Andreas M Boehmler, Lothar Kanz, et al.Rheumatology International|December 17, 2009
Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritisJoerg Christoph Henes, Joerg Schedel, Lothar Kanz, et al.Journal of Cancer Research and Clinical Oncology|December 24, 2004
Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantationWichard Vogel, Hans-Georg Kopp, Lothar Kanz, et al.Pageof 21